Sunifiram® CAS:314728-85-3

Sunifiram (DM-235) es un derivado sintético de Piracetam, aunque debido a la ruptura de la columna vertebral de la pirrolidona, ya no se encuentra en la clase de medicamentos Racetam (sin embargo, al derivarse de ellos, todavía se asocia comúnmente con esta clase).

Sunifiram Applications:

Sunifiram is one of the newest nootropics on the market to smart drugs family. It is considered to be in the ampakine family of supplements. It increases one’s attention span, decision making, and learning abilities. Although it is believed to work much like Piracetam, it is highly potent in comparison. The structure is similar, but some have reported Sunifiram being 1000 times more potent. In terms of its potency, it’s comparable to Noopept.

It is being researched as a memory enhancer, potentially treating Alzheimer’s patients. It provides a wide variety of benefits including; increased attention span, improved focus, and increased learning potential. It has become very popular since its release, as the benefits are high and the side-effects are low.

Sunifiram activates AMPA-mediated neurotransmission.

Enhancing LTP in a bell-shaped dose-response relationship.

Sunifiram aids in the release of acetylcholine in the cerebral cortex.

Sunifiram increases energy levels, permitiendo a los usuarios sentirse más motivados y eliminar

Aumento de sunifiram Aumento de los niveles de concentración, y los usuarios se sienten menos distraídos por estímulos externos.

Sunifiram también mejora la potenciación a largo plazo, que es la formación de nuevas conexiones con respecto al almacenamiento de memoria.

Sunifiram tiene algunos beneficios ansiolíticos. Sentirse más relajado es beneficioso cuando se trata de concentrarse.